The present invention relates to a 8-azabicyclo[3.2.1]octane derivative of Formula I,
wherein each of the substituents is given the definition as set forth in the specification and claims, or a pharmaceutically acceptable salt thereof or solvate thereof. The present invention also relates to a pharmaceutical composition comprising an 8-azabicyclo[3.2.1]octane derivative in admixture with one or more pharmaceutically acceptable auxiliaries and to the use of the 8-azabicyclo[3.2.1]octane derivative in therapy.
There is provided compounds of formula I,
wherein R
1
to R
7
have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
The present invention relates to a 8-azabicyclo[3.2.1] octane derivative of Formula I,
wherein each of the substituents is given the definition as set forth in the specification and claims, or a pharmaceutically acceptable salt thereof or solvate thereof. The present invention also relates to a pharmaceutical composition comprising an 8-azabicyclo [-3.2.1] octane derivative in admixture with one or more pharmaceutically acceptable auxiliaries and to the use of the 8-azabicyclo[3.2.1] octane derivative in therapy.
AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME
申请人:Funahashi Masakazu
公开号:US20140312340A1
公开(公告)日:2014-10-23
An aromatic amine derivative is represented by the following formula (1), in which R
1
to R
5
and R
7
to R
11
are each independently a hydrogen atom or a substituent. In the formula (1), R
6
and R
12
are each represented by the following formula (2) and L
1
to L
3
are each independently a single bond, a divalent residue of an aryl group, or the like. Ar
1
in the formula (2) is a monovalent substituent having a moiety represented by the following formula (3), in which X is an oxygen atom or a sulfur atom. Ar
2
in the formula (2) is a substituted or unsubstituted aryl group or the like.